[NH2:1][C:2]1[N:3]=[C:4]2[CH:9]=[CH:8][C:7]([O:10][C:11]3[CH:12]=[C:13]([NH:17][C:18]([C:20]4[C:25]([CH3:26])=[CH:24][CH:23]=[CH:22][N:21]=4)=[O:19])[CH:14]=[CH:15][CH:16]=3)=[CH:6][N:5]2[CH:27]=1.[N:28]1[CH:33]=[CH:32][CH:31]=[C:30]([C:34](O)=[O:35])[CH:29]=1.Cl.CN(C)CCCN=C=NCC.N1(O)C2C=CC=CC=2N=N1.C(N(CC)C(C)C)(C)C>C(=O)([O-])O.[Na+].CN(C)C(=O)C>[CH3:26][C:25]1[C:20]([C:18]([NH:17][C:13]2[CH:14]=[CH:15][CH:16]=[C:11]([O:10][C:7]3[CH:8]=[CH:9][C:4]4[N:5]([CH:27]=[C:2]([NH:1][C:34]([C:30]5[CH:29]=[N:28][CH:33]=[CH:32][CH:31]=5)=[O:35])[N:3]=4)[CH:6]=3)[CH:12]=2)=[O:19])=[N:21][CH:22]=[CH:23][CH:24]=1A mixture of N-{3-[(2-aminoimidazo[1,2-a]pyridin-6-yl)oxy]phenyl}-3-methylpyridine-2-carboxamide (150 mg, 0.625 mmol), pyridine-3-carboxylic acid (76.9 mg, 0.625 mmol), N-[3-(dimethylamino)propyl]-N′-ethylcarbodiimide hydrochloride (132 mg, 0.689 mmol), 1H-benzotriazol-1-ol (58.0 mg, 0.429 mmol), N,N-diisopropylethylamine (143 μL, 0.835 mmol) and N,N-dimethylacetamide (5 mL) was stirred at room temperature for 13 hr. The reaction mixture was diluted with aqueous sodium hydrogen carbonate solution and extracted with ethyl acetate. The organic layer was washed with aqueous sodium hydrogen carbonate solution and saturated brine, dried over anhydrous magnesium sulfate and filtrated. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (NH silica gel, 0%→75% ethyl acetate-hexane) to give the title compound (89.0 mg, 46%) as a pale-yellow solid.